JS InnoPharm, LLC
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ERK Inhibitor JSI-1187 in Advanced Solid Tumors (NCT06239623) | JS InnoPharm, LLC | 2022-04-02 |
| JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations (NCT04418167) | JS InnoPharm, LLC | 2020-06-18 |
Track JS InnoPharm, LLC automatically
Every clearance here is in the API, with alerts when new ones post.